SAN CARLOS, Calif.--(BUSINESS WIRE)--The Lipoprotein(a) Foundation announced today that it has expanded its global Scientific Advisory Board (SAB) to 27 members. The Advisory Board, comprised of the world’s leading experts on Lipoprotein(a), a highly prevalent, independent, genetic risk factor for early cardiovascular disease, provides support to the Foundation’s mission of saving lives by increasing awareness, advocating for routine testing, and supporting research that will lead to a specific treatment for elevated Lipoprotein(a).
